HISTORY

~CURRENT
2024
  • Jul.

    Signed a MOU with Modalis Therapeutics Corporation, jointly developing a XOB031-mediated AAV gene therapy for Alzheimer’s disease

  • Jun.

    ODD request of GXC-301, a therapeutic agent for Lafora disease, granted by US FDA

    Selected as a ‘2024 UNICORN’ and raised UDS 2M (Global Unicorn Project by Ministry of SMEs and Startups)

  • May.

    RPDD request of GXC-301, a therapeutic agent for Lafora disease, granted by US FDA

    InsightMiner™, won a prize and a award at AI Rocket Launcher Day Season4, 2024 AI EXPO

  • Apr.

    A ‘co-developing’ Alzheimer’s disease therapeutic program with Hanyang Univ., funded by a governmental global R&D program from KHIDI

  • Feb.

    MOU signed with AJOU MBD T2B Center

    Change of corporate name to GENIXCURE Inc.

  • Feb.

    Filed 4 patents of AI-based cell-specific peptides & AAVs (featuring 60 vectors)

2019~2023
2023
  • Oct.

    Made a presentation of GXC-301(Lafora disease) preclinical data at 2023 Lafora Disease Science Symposium in Bologna, Italy

  • Jul.

    Filed a patent application for GXC301, a therapeutic agent for Lafora disease

  • Jun.

    Made a presentation of an AAV program at ISCT 2023 in Paris (Collaborative research with Samsung Seoul Hospital)

  • Apr.

    Signed MOUs with Kyungdong Pharmaceutical Co., Ltd. for GMP CDMO and L/O

2022
  • Dec.

    Signed Research and Development Agreement with ToolGen

    Inno-Biz Certification (Minister of Small and Medium Venture Business)

  • Jul.

    Participation in R&D projects to foster research-oriented hospitals (supervisor: Samsung Seoul Hospital)

  • Feb.

    Series A fundraising

  • Jan.

    TF launched for InsightMiner™ 1.0

2021
  • Dec.

    Signed a MOU with MedySapiens

  • Jun.

    GXC101 funded by a government R&D program by KHIDI

  • May.

    GXC301 funded by a government R&D program by Ministry of SMEs and Startups

2020
  • Dec.

    Awarded ‘Appreciation of Technology Commercialization & Entrepreneurship’ from Ministry of Health and Welfare

    GXC101 funded 1M by a government R&D program by Ministry of Health and Welfare

  • Jul.

    Certification of venture companies

    GXC-101 patent registered in the US

  • Jan.

    Certification of corporate research institutes

2019
  • Jun.

    GXC-101 in licensing from IBS & DGIST

  • Apr.

    Founded